annual cash & cash equivalents:
$779.71M+$185.71M(+31.26%)Summary
- As of today (August 20, 2025), PTCT annual cash & cash equivalents is $779.71 million, with the most recent change of +$185.71 million (+31.26%) on December 31, 2024.
- During the last 3 years, PTCT annual cash & cash equivalents has risen by +$589.99 million (+310.98%).
- PTCT annual cash & cash equivalents is now at all-time high.
Performance
PTCT Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$1.99B-$38.03M(-1.88%)Summary
- As of today (August 20, 2025), PTCT quarterly cash & cash equivalents is $1.99 billion, with the most recent change of -$38.03 million (-1.88%) on June 30, 2025.
- Over the past year, PTCT quarterly cash & cash equivalents has increased by +$895.86 million (+81.94%).
- PTCT quarterly cash & cash equivalents is now -1.88% below its all-time high of $2.03 billion, reached on March 31, 2025.
Performance
PTCT quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
PTCT Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +31.3% | +81.9% |
| 3 y3 years | +311.0% | +293.5% |
| 5 y5 years | +170.7% | +298.7% |
PTCT Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +311.0% | -1.9% | +589.6% |
| 5 y | 5-year | at high | +311.0% | -1.9% | +589.6% |
| alltime | all time | at high | >+9999.0% | -1.9% | >+9999.0% |
PTCT Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $1.99B(-1.9%) |
| Mar 2025 | - | $2.03B(+77.9%) |
| Dec 2024 | $779.71M(+31.3%) | $1.14B(+12.5%) |
| Sep 2024 | - | $1.01B(-7.3%) |
| Jun 2024 | - | $1.09B(+23.6%) |
| Mar 2024 | - | $884.81M(+0.9%) |
| Dec 2023 | $594.00M(+112.3%) | $876.74M(+197.4%) |
| Sep 2023 | - | $294.81M(-12.8%) |
| Jun 2023 | - | $337.94M(+0.5%) |
| Mar 2023 | - | $336.30M(-18.1%) |
| Dec 2022 | $279.83M(+47.5%) | $410.70M(+42.4%) |
| Sep 2022 | - | $288.43M(-42.9%) |
| Jun 2022 | - | $505.55M(-14.0%) |
| Mar 2022 | - | $587.79M(-24.0%) |
| Dec 2021 | $189.72M(-9.1%) | $773.38M(-10.9%) |
| Sep 2021 | - | $867.94M(-8.4%) |
| Jun 2021 | - | $947.08M(-4.2%) |
| Mar 2021 | - | $988.41M(-10.4%) |
| Dec 2020 | $208.81M(-27.5%) | $1.10B(-3.3%) |
| Sep 2020 | - | $1.14B(+128.7%) |
| Jun 2020 | - | $498.89M(-16.3%) |
| Mar 2020 | - | $595.86M(-13.2%) |
| Dec 2019 | $288.03M(+69.9%) | $686.56M(-3.1%) |
| Sep 2019 | - | $708.65M(+94.9%) |
| Jun 2019 | - | $363.54M(-10.7%) |
| Mar 2019 | - | $407.16M(+78.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $169.50M(+51.6%) | $227.59M(-8.7%) |
| Sep 2018 | - | $249.40M(-15.8%) |
| Jun 2018 | - | $296.11M(+66.1%) |
| Mar 2018 | - | $178.27M(-6.8%) |
| Dec 2017 | $111.79M(+91.7%) | $191.25M(+13.0%) |
| Sep 2017 | - | $169.31M(-6.5%) |
| Jun 2017 | - | $181.07M(-10.6%) |
| Mar 2017 | - | $202.58M(-12.6%) |
| Dec 2016 | $58.32M(+0.5%) | $231.67M(-6.7%) |
| Sep 2016 | - | $248.34M(-9.0%) |
| Jun 2016 | - | $272.89M(-8.6%) |
| Mar 2016 | - | $298.71M(-11.9%) |
| Dec 2015 | $58.02M(+16.6%) | $338.93M(-8.8%) |
| Sep 2015 | - | $371.52M(+45.6%) |
| Jun 2015 | - | $255.22M(-9.0%) |
| Mar 2015 | - | $280.47M(-11.0%) |
| Dec 2014 | $49.75M(+222.7%) | $315.24M(+50.6%) |
| Sep 2014 | - | $209.39M(-7.7%) |
| Jun 2014 | - | $226.86M(-8.0%) |
| Mar 2014 | - | $246.59M(+73.1%) |
| Dec 2013 | $15.41M(+465.5%) | $142.47M(-9.4%) |
| Sep 2013 | - | $157.23M(-5.1%) |
| Jun 2013 | - | $165.68M(+202.6%) |
| Mar 2013 | - | $54.75M(+1908.5%) |
| Dec 2012 | $2.73M(-90.4%) | $2.73M |
| Dec 2011 | $28.43M | - |
FAQ
- What is PTC Therapeutics, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
- What is PTC Therapeutics, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
What is PTC Therapeutics, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of PTCT is $779.71M
What is the all time high annual cash & cash equivalents for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high annual cash & cash equivalents is $779.71M
What is PTC Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, PTCT annual cash & cash equivalents has changed by +$185.71M (+31.26%)
What is PTC Therapeutics, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of PTCT is $1.99B
What is the all time high quarterly cash & cash equivalents for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high quarterly cash & cash equivalents is $2.03B
What is PTC Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, PTCT quarterly cash & cash equivalents has changed by +$895.86M (+81.94%)